SSRI Selection After Stroke

Post-Stroke Depression Management

Patients diagnosed with post-stroke depression should be treated with an SSRI, with sertraline being the preferred first-line option due to its favorable safety profile and effectiveness in improving functional recovery, as recommended by the American Heart Association 1
SSRIs are the recommended first-line pharmacological treatment for post-stroke depression due to their efficacy in reducing depressive symptoms and favorable side effect profile compared to other antidepressants, according to the American Heart Association 1
Routine screening for depression using structured inventories such as the Patient Health Questionnaire-2 is recommended for all stroke patients, as suggested by the American Heart Association 1
Treatment with antidepressants should be initiated when post-stroke depression is diagnosed, in the absence of contraindications, as recommended by the American Heart Association 1
Periodic reassessment of depression, anxiety, and other psychiatric symptoms is useful in the ongoing care of stroke survivors, as recommended by the American Heart Association 1
Avoid assuming all post-stroke mood changes are depression; screen properly to differentiate from emotional lability or pseudobulbar affect, as recommended by the American Heart Association 1
Do not delay treatment once post-stroke depression is diagnosed, as early effective treatment may positively affect rehabilitation outcomes, as recommended by the American Heart Association 1

For other SSRIs, follow standard dosing protocols, such as Duloxetine: Start with 20-30 mg once daily, then increase weekly to goal of 60 mg/day (maximum 120 mg/day), as recommended by the American College of Cardiology 2
Venlafaxine: Start with 37.5 mg once or twice daily, increase by 75 mg each week to maximum of 225 mg/day, as recommended by the Mayo Clinic 3

Avoid using tricyclic antidepressants as first-line therapy due to their less favorable side effect profile in stroke patients, as recommended by the American Heart Association and the Mayo Clinic 1, 3
The concept of enhancing brain plasticity through SSRIs has been suggested by animal studies, but multiple clinical studies of fluoxetine have not shown beneficial effects on functional outcome, as reported by the American Heart Association 4

During the acute phase of stroke management, focus on blood pressure control and other critical care measures before initiating antidepressant therapy, according to the American Heart Association, as stated in the Stroke journal 5
If initiating sertraline during hospitalization for acute stroke, ensure it doesn't interfere with other critical medications or blood pressure management, as recommended by the American Heart Association, based on evidence from the Stroke journal 5